跳至主要内容
临床试验/NCT03481101
NCT03481101Unknown不适用

WHENII - Early Response Evaluation With 18F-2-fluoro-2-deoxy-D-glucose Fluorodeoxyglucose(FDG)- Positrons Emissions Tomography(PET)/CT and Liquid Biopsy in Patients With NSCLC (Non Small Cell Lung Cancer)

Rigshospitalet, Denmark3 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年2月28日最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
3
主要终点
Observation of changes in metabolism in cancer cells during first treatment with chemotherapy or immunotherapy.

研究概览

简要总结

Response evaluation with FDG-PET and free circulating DNA in patients with inoperable lung cancer of non small cell type during first treatment with chemotherapy or immunotherapy.

详细描述

Interventional study of patients with inoperable lung cancer of non small cell type undergoing 1st treatment of either chemotherapy or immunotherapy. Patients are evaluated with FDG-PET/ct and blood analyses og circulating tumor DNA and cancer markers to determine early response.

PET-CT are preceded before and after treatment is given;

  • day 0 before treatment,
  • day 2 after treatment and
  • day 21 just before second treatment. At every FDG-PET/ct scan blood are examined for circulating tumor DNA (ctDNA) and potentially cancer markers by White genome sequencing. In total 3 PET-CT scans and 4 blood samples are performed. The result are compared with the standard CT scan after 2-3 cycles of treatment. Blood analyses are repeated after 2-3 cycles to observe any changes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with non-small cell lung cancer (NSCLC) who is about to start treatment with chemo- or immune therapy. No prior treatment of the one given.
  • Measurable decease according to RECIST criteria
  • Age > 18 years
  • Performance status 0-2 (0-1 for immunotherapy)
  • Understands and reads danish

排除标准

  • Poor performance status
  • Secondary active cancer
  • Pregnancy
  • Dysregulated diabetes mellitus

结局指标

主要结局

Observation of changes in metabolism in cancer cells during first treatment with chemotherapy or immunotherapy.

时间窗: 3 months

Measure changes in standardized uptake value (SUV) in tumorcells by FDG-PET.

Observation of changes in circulating tumor DNA during first treatment.

时间窗: 3 months

Measure changes in the amount of free circulating DNA

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

heidi ryssel

Doctor

Rigshospitalet, Denmark

研究点 (3)

Loading locations...

相似试验

WHENII - Early Response Evaluation With FDG-PET/CT... | 临床试验